 |
 |

Use of Alendronate After 5 Years of Treatment
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In the conclusions of the report on the Fracture Intervention Trial (FIT) Long-term Extension (FLEX), Dr Black and colleagues1 state that "the results confirm the safety of alendronate for up to 10 years including no increased fracture risk with long-term alendronate use."1 However, we do not believe that this study design warrants this conclusion. There is no group that received only placebo; those patients included in the "placebo" group had previously received alendronate for a mean of 5 years. Therefore, long-term alendronate safety cannot be determined from this study and requires a different trial.
In addition, patients who had taken alendronate, either 5 mg/d or 10 mg/d, in the FIT study were included in the same group for the FLEX study. It would be interesting to know the incidence of fractures in these 2 populations separately and whether there is any dose-related effect.
Finally, statistically significant higher . . . [Full Text of this Article]
Juan Erviti, PharmD, PhD
jervitil@cfnavarra.es
Javier Gorricho, PharmD
Drug Prescribing Service Servicio Navarro de Salud Pamplona, Spain
RELATED LETTERS
Use of Alendronate After 5 Years of Treatment
Susan M. Ott
JAMA. 2007;297(18):1979.
EXTRACT
| FULL TEXT
Use of Alendronate After 5 Years of Treatment
Pierre D. Delmas
JAMA. 2007;297(18):1979-1980.
EXTRACT
| FULL TEXT
Use of Alendronate After 5 Years of TreatmentReply
Dennis M. Black, Ann V. Schwartz, Steven R. Cummings, Jane A. Cauley, and Lisa Palermo
JAMA. 2007;297(18):1980-1981.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Effects of Continuing or Stopping Alendronate After 5 Years of Treatment: The Fracture Intervention Trial Long-term Extension (FLEX): A Randomized Trial
Dennis M. Black, Ann V. Schwartz, Kristine E. Ensrud, Jane A. Cauley, Silvina Levis, Sara A. Quandt, Suzanne Satterfield, Robert B. Wallace, Douglas C. Bauer, Lisa Palermo, Lois E. Wehren, Antonio Lombardi, Arthur C. Santora, Steven R. Cummings, and for the FLEX Research Group
JAMA. 2006;296(24):2927-2938.
ABSTRACT
| FULL TEXT
|